General Information
Version
1.01
Revision date
2025-01-10
Product name
Ergotaminine
Substance name
C33 H35 N5 O5
Chemical name
Ergotaminine
CAS No.
639-81-6
1.2.1 Relevant identified uses
Laboratory use
supplier name
LGC Limited
Emergency telephone
1-800-424-9300, +1 703-741-3877
Icons in SDS
Company Information
company name
LGC Limited
e-mail address of the competent person responsible for the Safety Data Sheet
gb@lgcstandards.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H311, H331, H361, H362
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Ergotaminine
Signal word
Danger
Hazard statements
H301 - Toxic if swallowed H311 - Toxic in contact with skin H331 - Toxic if inhaled H361 - Suspected of damaging fertility or the unborn child H362 - May cause harm to breast-fed children
Precautionary statements
P260 - Do not breathe dust, fume, gas, mist, vapors and spray P263 - Avoid contact during pregnancy and while nursing P280 - Wear protective gloves, protective clothing, eye protection and face protection P301 + P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor P403 + P233 - Store in a well-ventilated place. Keep container tightly closed
2.3 Other hazards
No information available. This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity - Oral Category 3 - (H301) Acute toxicity - Dermal Category 3 - (H311) Acute toxicity - Inhalation (Dusts/Mists) Category 3 - (H331) Reproductive toxicity Category 2 - (H361) Effects on or via lactation Yes - (H362)
